Skip to main content

Find Clinical Trials

Home
Conditions
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia

Clinical trial condition

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia

Explore clinical trials studying Adult Patients With Adverse Risk Acute Myeloblastic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia trial results

Recruiting

Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)

NCT05749276

Conditions: Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
Locations: CHU de Nantes Nantes, France

View Trial Details